406 related articles for article (PubMed ID: 37549657)
21. Advancement of nanoscience in development of conjugated drugs for enhanced disease prevention.
Taneja P; Sharma S; Sinha VB; Yadav AK
Life Sci; 2021 Mar; 268():118859. PubMed ID: 33358907
[TBL] [Abstract][Full Text] [Related]
22. Advances in the synthesis and application of nanoparticles for drug delivery.
Park W; Na K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
[TBL] [Abstract][Full Text] [Related]
23. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
24. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
Raza F; Zafar H; You X; Khan A; Wu J; Ge L
J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
[TBL] [Abstract][Full Text] [Related]
25. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
Kaur M; Nagpal M; Aggarwal G
Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
[TBL] [Abstract][Full Text] [Related]
26. Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders.
Kumar S; Singh P; Sharma S; Pottoo FH; Ali J; Baboota S
Comb Chem High Throughput Screen; 2021; 24(10):1544-1556. PubMed ID: 33334281
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles in Drug Delivery: From History to Therapeutic Applications.
Afzal O; Altamimi ASA; Nadeem MS; Alzarea SI; Almalki WH; Tariq A; Mubeen B; Murtaza BN; Iftikhar S; Riaz N; Kazmi I
Nanomaterials (Basel); 2022 Dec; 12(24):. PubMed ID: 36558344
[TBL] [Abstract][Full Text] [Related]
28. Nanomedicine-nanoscale drugs and delivery systems.
Singh S
J Nanosci Nanotechnol; 2010 Dec; 10(12):7906-18. PubMed ID: 21121278
[TBL] [Abstract][Full Text] [Related]
29. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
[TBL] [Abstract][Full Text] [Related]
30. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
Al-Jamal WT; Kostarelos K
Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
[TBL] [Abstract][Full Text] [Related]
31. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
Luo MX; Hua S; Shang QY
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
[TBL] [Abstract][Full Text] [Related]
32. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
33. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
Bertalan F; László B; Attila V
Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
[TBL] [Abstract][Full Text] [Related]
34. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
35. Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization.
Timin AS; Litvak MM; Gorin DA; Atochina-Vasserman EN; Atochin DN; Sukhorukov GB
Adv Healthc Mater; 2018 Feb; 7(3):. PubMed ID: 29193876
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
[TBL] [Abstract][Full Text] [Related]
37. Nanomedicines for the treatment of hematological malignancies.
Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
[TBL] [Abstract][Full Text] [Related]
38. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
Ozeki T; Tagami T
Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle Based Treatment for Cardiovascular Diseases.
Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
[TBL] [Abstract][Full Text] [Related]
40. Promising Nanomedicines of Shikonin for Cancer Therapy.
Yan C; Li Q; Sun Q; Yang L; Liu X; Zhao Y; Shi M; Li X; Luo K
Int J Nanomedicine; 2023; 18():1195-1218. PubMed ID: 36926681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
